Bridgebio Pharma, Inc.
Ticker: BBIO
| Insider | Title |
|---|---|
| Ali J. Satvat | Director |
| Andrea Ellis | Director |
| Andrew Lo | Director |
| Brent L Saunders | Director |
| Brian C Stephenson | Secretary, Treasurer CFO |
| Charles J Homcy | Director |
| Co. Inc. Kkr | 10% or greater ownership |
| Douglas A. Dachille | Director |
| Eric Aguiar | Director |
| Frank Mccormick | Director |
| Fred Hassan | Director |
| Genetic Disorder Gp Llc Kkr | 10% or greater ownership |
| Genetic Disorder L.p. Kkr | 10% or greater ownership |
| George R Roberts | 10% or greater ownership |
| Group Co. Inc. Kkr | 10% or greater ownership |
| Group Holdings Corp. Kkr | 10% or greater ownership |
| Group Partnership L.p. Kkr | 10% or greater ownership |
| Hannah Valantine | Director |
| Henry R Kravis | 10% or greater ownership |
| James C Momtazee | Director |
| Jennifer E. Cook | Director |
| Management Llp Kkr | 10% or greater ownership |
| Neil Kumar | Chief Executive Officer, Director |
| Randal W. Scott | Director |
| Richard H Scheller | Director |
| Ronald J Daniels | Director |
| Thomas Trimarchi | President and COO |